Micro Cap Growth Fund
Daily price w/o sales charge as of 08/13/2026
$25.79
$0.12
YTD Returns w/o sales charge as of 08/13/2026
32.32%
Overall Morningstar RatingsSmall Growth
as of 07/31/2026
Morningstar rated the Lord Abbett Micro Cap Growth Fund class A share 4, 3 and 5 stars among 522, 499 and 403 Small Growth Funds for the overall rating and the 3, 5 and 10 year periods ended 7/31/2026, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 07/31/2026
- Total Net Assets
- $213.01 M
- Inception Date
- 05/01/2000
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 1.37%
- Fund Net Expense Ratio
- 1.37%
- Number of Holdings
- 83
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 24.58% | 43.58% | 17.73% | 5.03% | 16.92% | 10.98% |
| Lipper Category Avg. Small-Cap Growth Funds | 13.39% | 22.60% | 12.34% | 3.20% | 11.02% | - |
| Russell Microcap® Growth Index | 10.39% | 31.43% | 17.97% | 2.46% | 8.98% | - |
| w/ sales charge | 17.41% | 35.34% | 15.42% | 3.79% | 16.23% | 10.73% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 35.45% | 57.71% | 22.39% | 5.64% | 18.91% | 11.37% |
| Lipper Category Avg. Small-Cap Growth Funds | 21.87% | 33.76% | 16.35% | 4.55% | 12.40% | - |
| Russell Microcap® Growth Index | 23.50% | 51.30% | 23.15% | 3.30% | 10.79% | - |
| w/ sales charge | 27.66% | 48.65% | 19.99% | 4.40% | 18.21% | 11.12% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
TEN LARGEST HOLDINGS as of 06/30/2026View Portfolio
| Holding | Assets |
|---|---|
| Cardinal Infrastructure Group Inc | 3.1% |
| Cogent Biosciences Inc | 3.0% |
| Aehr Test Systems | 2.8% |
| CECO Environmental Corp | 2.6% |
| Terawulf Inc | 2.4% |
| Adaptive Biotechnologies Corp | 2.3% |
| Mercury Systems Inc | 2.1% |
| Navan Inc | 2.0% |
| Bel Fuse Inc | 2.0% |
| Enliven Therapeutics Inc | 2.0% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 07/31/2026View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 24.58% | 43.58% | 17.73% | 5.03% | 16.92% | 10.98% |
| Lipper Category Avg. Small-Cap Growth Funds | 13.39% | 22.60% | 12.34% | 3.20% | 11.02% | - |
| Russell Microcap® Growth Index | 10.39% | 31.43% | 17.97% | 2.46% | 8.98% | - |
| w/ sales charge | 17.41% | 35.34% | 15.42% | 3.79% | 16.23% | 10.73% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 35.45% | 57.71% | 22.39% | 5.64% | 18.91% | 11.37% |
| Lipper Category Avg. Small-Cap Growth Funds | 21.87% | 33.76% | 16.35% | 4.55% | 12.40% | - |
| Russell Microcap® Growth Index | 23.50% | 51.30% | 23.15% | 3.30% | 10.79% | - |
| w/ sales charge | 27.66% | 48.65% | 19.99% | 4.40% | 18.21% | 11.12% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
| Year | Fund Returns | Russell Microcap® Growth Index |
|---|
| 2025 | 10.74% | 21.84% |
| 2024 | 26.89% | 21.91% |
| 2023 | 5.88% | 9.11% |
| 2022 | -29.27% | -29.76% |
| 2021 | 3.46% | 0.88% |
| 2020 | 79.42% | 40.13% |
| 2019 | 34.57% | 23.33% |
| 2018 | 2.74% | -14.18% |
| 2017 | 38.43% | 16.65% |
| 2016 | 2.07% | 6.86% |
| 2015 | -6.38% | - |
| 2014 | 10.83% | - |
| 2013 | 78.53% | - |
| 2012 | 2.35% | - |
| 2011 | -5.87% | - |
| 2010 | 33.77% | - |
| 2009 | 52.61% | - |
| 2008 | -46.45% | - |
| 2007 | 22.76% | - |
| 2006 | 25.37% | - |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|
| 2026 | 0.21% | 35.18% | - | - |
| 2025 | -17.90% | 15.85% | 13.92% | 2.20% |
| 2024 | 7.64% | 0.07% | 6.89% | 10.21% |
| 2023 | 5.50% | 4.20% | -13.40% | 11.23% |
| 2022 | -17.22% | -22.57% | 8.17% | 2.02% |
| 2021 | 12.29% | -0.15% | -9.42% | 1.87% |
| 2020 | -24.28% | 47.61% | 17.48% | 36.65% |
| 2019 | 22.67% | 7.47% | -13.91% | 18.57% |
| 2018 | 5.24% | 15.77% | 10.08% | -23.39% |
| 2017 | 9.00% | 8.12% | 13.61% | 3.39% |
| 2016 | -13.70% | 6.01% | 14.49% | -2.55% |
| 2015 | 7.33% | 4.15% | -16.30% | 0.06% |
| 2014 | 7.92% | -6.53% | -6.55% | 17.58% |
| 2013 | 21.83% | 15.00% | 17.29% | 8.65% |
| 2012 | 17.67% | -9.76% | 1.32% | -4.87% |
| 2011 | 4.82% | 0.11% | -21.90% | 14.86% |
| 2010 | 6.60% | -8.74% | 15.08% | 19.49% |
| 2009 | -0.95% | 31.46% | 13.47% | 3.29% |
| 2008 | -23.22% | 4.46% | -5.93% | -29.02% |
| 2007 | 5.64% | 9.81% | 4.01% | 1.76% |
| 2006 | 17.15% | -9.83% | 1.22% | 17.25% |
| 2005 | -9.50% | 5.88% | 6.91% | 0.10% |
| 2004 | 12.33% | 1.65% | -11.11% | 24.03% |
| 2003 | -3.55% | 27.29% | 11.68% | 8.93% |
| 2002 | -0.18% | -12.74% | -21.79% | 1.33% |
| 2001 | 2.34% | 12.03% | -21.11% | 29.32% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 07/31/2026
The chart begins on the Fund's inception date of 05/01/2000.
Based on a hypothetical Class A share investment of $10,000 on 05/01/2000 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Cardinal Infrastructure Group Inc | Industrials | 3.1% |
| Cogent Biosciences Inc | Health Care | 3.0% |
| Aehr Test Systems | Information Technology | 2.8% |
| CECO Environmental Corp | Industrials | 2.6% |
| Terawulf Inc | Information Technology | 2.4% |
| Adaptive Biotechnologies Corp | Health Care | 2.3% |
| Mercury Systems Inc | Industrials | 2.1% |
| Navan Inc | Consumer Discretionary | 2.0% |
| Bel Fuse Inc | Information Technology | 2.0% |
| Enliven Therapeutics Inc | Health Care | 2.0% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Cardinal Infrastructure Group Inc | Industrials | 3.1% |
| Cogent Biosciences Inc | Health Care | 3.0% |
| Aehr Test Systems | Information Technology | 2.8% |
| CECO Environmental Corp | Industrials | 2.6% |
| Terawulf Inc | Information Technology | 2.4% |
| Adaptive Biotechnologies Corp | Health Care | 2.3% |
| Mercury Systems Inc | Industrials | 2.1% |
| Navan Inc | Consumer Discretionary | 2.0% |
| Bel Fuse Inc | Information Technology | 2.0% |
| Enliven Therapeutics Inc | Health Care | 2.0% |
| Xometry Inc | Industrials | 1.9% |
| Pattern Group Inc | Consumer Discretionary | 1.9% |
| Hinge Health Inc | Health Care | 1.9% |
| Celcuity Inc | Health Care | 1.8% |
| 10X Genomics Inc | Health Care | 1.8% |
| Lindblad Expeditions Holdings Inc | Consumer Discretionary | 1.8% |
| Sphere Entertainment Co | Communication Services | 1.7% |
| Lincoln Educational Services Corp | Consumer Discretionary | 1.7% |
| Applied Digital Corp | Information Technology | 1.7% |
| Dianthus Therapeutics Inc | Health Care | 1.6% |
| Ouster Inc | Information Technology | 1.5% |
| AAR Corp | Industrials | 1.5% |
| Applied Optoelectronics Inc | Information Technology | 1.4% |
| MYR Group Inc | Industrials | 1.4% |
| IMAX Corp | Communication Services | 1.4% |
| Navitas Semiconductor Corp | Information Technology | 1.4% |
| Argan Inc | Industrials | 1.4% |
| Chefs' Warehouse Inc/The | Consumer Staples | 1.4% |
| Legence Corp | Industrials | 1.3% |
| Mirum Pharmaceuticals Inc | Health Care | 1.3% |
| Ambiq Micro Inc | Information Technology | 1.2% |
| Nektar Therapeutics | Health Care | 1.2% |
| Neptune Insurance Holdings Inc | Financials | 1.2% |
| Billiontoone Inc | Health Care | 1.2% |
| Vita Coco Co Inc/The | Consumer Staples | 1.2% |
| PTC Therapeutics Inc | Health Care | 1.2% |
| Universal Technical Institute Inc | Consumer Discretionary | 1.2% |
| Mama's Creations Inc | Consumer Staples | 1.2% |
| Praxis Precision Medicines Inc | Health Care | 1.2% |
| StoneX Group Inc | Financials | 1.1% |
| VSE Corp | Industrials | 1.1% |
| Tarsus Pharmaceuticals Inc | Health Care | 1.1% |
| Oruka Therapeutics Inc | Health Care | 1.1% |
| Sterling Infrastructure Inc | Industrials | 1.0% |
| Twist Bioscience Corp | Health Care | 1.0% |
| Marex Group PLC | Financials | 1.0% |
| WisdomTree Inc | Financials | 1.0% |
| Miami International Holdings Inc | Financials | 1.0% |
| Newamsterdam Pharma Co NV | Health Care | 1.0% |
| Willdan Group Inc | Industrials | 0.9% |
| Relay Therapeutics Inc | Health Care | 0.9% |
| BlackSky Technology Inc | Industrials | 0.9% |
| TAT Technologies Ltd | Industrials | 0.9% |
| Standex International Corp | Industrials | 0.9% |
| Red Violet Inc | Information Technology | 0.8% |
| Dave Inc | Financials | 0.8% |
| Fastly Inc | Information Technology | 0.8% |
| Transcat Inc | Industrials | 0.7% |
| Innodata Inc | Industrials | 0.7% |
| Warby Parker Inc | Consumer Discretionary | 0.7% |
| HeartFlow Inc | Health Care | 0.7% |
| Unusual Machines Inc /US | Information Technology | 0.7% |
| Sezzle Inc | Financials | 0.7% |
| Mayville Engineering Co Inc | Industrials | 0.7% |
| Applied Aerospace & Defense Inc | Industrials | 0.7% |
| CG oncology Inc | Health Care | 0.7% |
| nLight Inc | Information Technology | 0.7% |
| Gilat Satellite Networks Ltd | Information Technology | 0.6% |
| Jade Biosciences Inc | Health Care | 0.6% |
| Cipher Digital Inc | Information Technology | 0.6% |
| Extreme Networks Inc | Information Technology | 0.6% |
| Alamar Biosciences Inc | Health Care | 0.6% |
| Vishay Precision Group Inc | Information Technology | 0.6% |
| Forte Biosciences Inc | Health Care | 0.5% |
| American Public Education Inc | Consumer Discretionary | 0.5% |
| Tyra Biosciences Inc | Health Care | 0.5% |
| York Space Systems Inc | Industrials | 0.5% |
| Ondas Inc | Information Technology | 0.4% |
| Piper Sandler Cos | Financials | 0.4% |
| Liftoff Mobile Inc | Communication Services | 0.2% |
| Hawkeye 360 Inc | Industrials | 0.0% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 07/31/2026
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
 0.1%
|
|
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Consumer Discretionary |
1.8%
|
|
| Consumer Staples |
1.0%
|
|
| Energy |
1.2%
|
|
| Financials | 0.0% | |
| Health Care |
3.3%
|
|
| Industrials |
4.9%
|
|
| Information Technology |
2.2%
|
|
| Materials | 0.0% |
Portfolio Details as of 07/31/2026
- Total Net Assets
- $213.01 M
- Number of Holdings
- 83
- Weighted Average Market Cap.
- 3.7 B
- P/B Ratio
- 6.6x
- P/E Ratio
- 47.9x
To view definitions for the above Portfolio Details, Click here.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 08/13/2026
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/20/2001 | 11/21/2001 | 11/21/2001 | $0.00740 | $10.09 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/23/2026 | 11/24/2026 | 11/24/2026 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/23/2020 | 11/24/2020 | $2.8043 | $2.2741 | $5.0784 | $15.43 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 08/13/2026
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $27.36 |
| $50,000 to $99,999 | 4.75% | 4.00% | $27.08 |
| $100,000 to $249,999 | 3.95% | 3.25% | $26.85 |
| $250,000 to $499,999 | 2.75% | 2.25% | $26.52 |
| $500,000 to $999,999 | 1.95% | 1.75% | $26.30 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $25.79 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 07/31/2026
| Fund Gross Expense Ratio | 1.37% |
| Fund Net Expense Ratio | 1.37% |
Fund Documents
Fund Documents
|
0Documents selected
|
||||
|---|---|---|---|---|
|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
|
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
||||
|
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
||||
|
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
2025 Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
2026 Semi-Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
Fact Sheet
Publish Date:11/03/2015
|